Keyuan Petrochemicals (KEYP) Stock Price, News & Analysis

Company Overview

Keyuan Petrochemicals, Inc., through its subsidiaries, Ningbo Keyuan, Ningbo Keyuan Petrochemicals, Keyuan Synthetic Rubbers, Guangxi Keyuan and Zhongkexuneng, is engaged in the manufacture and sale of petrochemical products and rubber in the People's Republic of China. The Company's segments include the manufacture and sale of petrochemical products (petrochemical segment) and the manufacture and sale of rubber products (rubber segment). The Petrochemicals Segment includes the manufacturing and sales of mixed light aromatics, mixed heavy aromatics, fine propylene, propane, butane, liquefied petroleum gas (LPG), methyltert-butylether and styrene. The Rubber Segment includes the manufacturing and sales of various rubber products. It manufactures and supplies various petrochemical and rubber products, including petrochemical products, such as Benzene Toluene-Xylene Aromatics (BTX Aromatics), propylene, styrene, LPG, Methyl Tertiary Butyl Ether (MTBE) and rubber products.

Key Stats

• Today's Range: $0.0035 to $0.0035
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.15
• Volume: 7,000 shs
• Average Volume: 4,541 shs
• Market Capitalization: $220,955.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KEYP Stock Analysis - Frequently Asked Questions

How have KEYP shares performed this year?

Keyuan Petrochemicals' stock was trading at $0.0035 on January 1st, 2024. Since then, KEYP stock has increased by 0.0% and is now trading at $0.0035.
View the best growth stocks for 2024 here.

How do I buy shares of Keyuan Petrochemicals?

Shares of KEYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Keyuan Petrochemicals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Keyuan Petrochemicals investors own include Titan Medical (TMD), BriaCell Therapeutics (BCT), Aurinia Pharmaceuticals (AUP), Athenex (ATNX), Athersys (ATHX), Antibe Therapeutics (ATE) and Apellis Pharmaceuticals (APLS).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:KEYP
• CUSIP: N/A
• CIK: 1326396
• Web: www.keyuanpetrochemicals.com
• Phone: +86-574-86232955
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 63,130,000
• Free Float: N/A
• Market Cap: $220,955.00
• Optionable: Not Optionable
• Beta: N/A